Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection
- PMID: 28751894
- PMCID: PMC5507946
- DOI: 10.3389/fimmu.2017.00819
Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection
Abstract
Respiratory syncytial virus (RSV) is a major cause of respiratory viral infections in infants and children. Alveolar macrophages (AMs) play a crucial role in combatting airborne pathogens, strongly express CD169, and are localized in the lung alveoli. Therefore, we used CD169-diphtheria toxin receptor (DTR) transgenic mice to explore the roles of CD169+ cells in immune responses to mucosal RSV infection. The administration of diphtheria toxin to CD169-DTR mice induced specific AM depletion and reduced the recruitment of Ly6Chi monocytes. Notably, CD169+ cell depletion reduced levels of innate cytokines, such as interferon-β, IL-6, and TNF-α, in bronchoalveolar lavage fluid during RSV infection without affecting the production of proinflammatory chemokines. Moreover, the depletion of CD169+ cells increased the recruitment of inflammatory cells to the lung during the early stage of RSV infection, although not during the later stages of RSV infection. Furthermore, the depletion of CD169+ cells reduced the recruitment of effector CD8+ T cells to the lungs after RSV mucosal infection. Our findings suggest that modulating the number of CD169+ cells to enhance immune responses to RSV infection may be useful as a new therapeutic strategy.
Keywords: CD169; CXCL9/10; alveolar macrophage; respiratory syncytial virus; type I interferon.
Figures
Similar articles
-
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.J Virol. 2015 Nov;89(22):11692-705. doi: 10.1128/JVI.02018-15. Epub 2015 Sep 9. J Virol. 2015. PMID: 26355098 Free PMC article.
-
GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation.J Allergy Clin Immunol. 2016 Mar;137(3):700-9.e9. doi: 10.1016/j.jaci.2015.09.031. Epub 2015 Nov 10. J Allergy Clin Immunol. 2016. PMID: 26560044
-
Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice.Respir Res. 2015 Oct 5;16:122. doi: 10.1186/s12931-015-0282-7. Respir Res. 2015. PMID: 26438053 Free PMC article.
-
Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review.Infect Drug Resist. 2022 Dec 14;15:7413-7430. doi: 10.2147/IDR.S387479. eCollection 2022. Infect Drug Resist. 2022. PMID: 36540102 Free PMC article. Review.
-
Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.Front Med (Lausanne). 2022 Sep 23;9:979373. doi: 10.3389/fmed.2022.979373. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36213653 Free PMC article. Review.
Cited by
-
CD169+ classical monocyte as an important participant in Graves' ophthalmopathy through CXCL12-CXCR4 axis.iScience. 2024 Feb 10;27(3):109213. doi: 10.1016/j.isci.2024.109213. eCollection 2024 Mar 15. iScience. 2024. PMID: 38439953 Free PMC article.
-
The innate immune brakes of the lung.Front Immunol. 2023 Jan 27;14:1111298. doi: 10.3389/fimmu.2023.1111298. eCollection 2023. Front Immunol. 2023. PMID: 36776895 Free PMC article. Review.
-
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.PLoS Pathog. 2022 Oct 24;18(10):e1010479. doi: 10.1371/journal.ppat.1010479. eCollection 2022 Oct. PLoS Pathog. 2022. PMID: 36279285 Free PMC article.
-
Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma.Nat Commun. 2022 Oct 20;13(1):6211. doi: 10.1038/s41467-022-34001-5. Nat Commun. 2022. PMID: 36266311 Free PMC article.
-
Role of Siglecs in viral infections: A double-edged sword interaction.Mol Aspects Med. 2023 Apr;90:101113. doi: 10.1016/j.mam.2022.101113. Epub 2022 Aug 16. Mol Aspects Med. 2023. PMID: 35981912 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
